3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
3
Nausea
3
Vomiting
2
Multiple Myeloma
2
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pain, Postoperative
1
Pain
1
Neuralgia
1
Lung Neoplasms
1
Leukemia, Biphenotypic, Acute
1
Intestinal Diseases
1
Inflammatory Bowel Diseases
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Digestive System Diseases
1
Crohn Disease
1
Colorectal Neoplasms
1
Interventions
Fentanyl
9
Acetaminophen
5
Zoledronic Acid
4
Oxycodone
4
Ketamine
4
Bupivacaine
4
Sufentanil
3
Hydromorphone
3
Diclofenac
3
Ropivacaine
2
Pregabalin
2
Morphine
2
Ketorolac
2
Ibuprofen
2
Ibandronic Acid
2
Esketamine
2
Epinephrine
2
naloxegol
1
chloroprocaine
1
acetaminophen, aspirin, caffeine drug combination
1
Varenicline
1
Uterine Artery Embolization
1
Ultracet
1
Therapeutics
1
Propofol
1
Pamidronate
1
Oxygen
1
Nitrous Oxide
1
Naproxen
1
Midazolam
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Pain
×
Calcium Dobesilate
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts